UPDATE ON ATYPICALS: Preemptive tactics to reduce weight gain
Teaching patients about appetite control before starting atypical antipsychotics can help keep excess pounds off.
Dr. Yu is a speaker for Cephalon Inc., Eli Lilly and Co., Novartis Pharmaceuticals Corp., and Pfizer Inc.; receives research/grant support from Cephalon, Inc. and Eli Lilly and Co.; and is a consultant to Eli Lilly and Co.
Dr. Maguire receives research support from, is a consultant to, and/or is a speaker for Eli Lilly and Co., Pfizer Inc., Forest Laboratories, and GlaxoSmithKline.
Acknowledgment
The authors wish to thank David Franklin, MS, neuroscientist; Chris Gordon, MD, resident; and Sam Truong, senior undergraduate student, University of California, Irvine, as well as Leanne Stoneking, MS, fourth-year medical student, Creighton University Medical School, for their assistance in preparing this manuscript.